Location History:
- Yamashina-ku, JP (2009)
- Kyoto, JP (2010)
Company Filing History:
Years Active: 2009-2010
Title: Innovations of Yukiteru Sugiyama
Introduction
Yukiteru Sugiyama is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit BCR-ABL tyrosine kinase activity. His work has led to the filing of multiple patents, showcasing his innovative approach to medicinal chemistry.
Latest Patents
Sugiyama's latest patents include an amide derivative and medicine that demonstrate excellent BCR-ABL tyrosine kinase inhibitory activity. The first patent describes an amide derivative represented by a specific general formula, which includes various substituents that enhance its efficacy. This compound is particularly useful as a BCR-ABL tyrosine kinase inhibitor. The second patent also focuses on an amide derivative with a different structural representation, emphasizing its potential as a pharmaceutical composition with similar inhibitory properties.
Career Highlights
Yukiteru Sugiyama is currently associated with Nippon Shinyaku Company, Ltd., where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that target specific cancer pathways. Sugiyama's innovative contributions have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Sugiyama has collaborated with esteemed colleagues such as Tetsuo Asaki and Jun Segawa. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Yukiteru Sugiyama's innovative work in the field of pharmaceuticals, particularly in the development of BCR-ABL tyrosine kinase inhibitors, highlights his significant contributions to medicinal chemistry. His patents reflect a commitment to advancing healthcare through innovative solutions.